0001730728-18-000005.txt : 20181226 0001730728-18-000005.hdr.sgml : 20181226 20181226120353 ACCESSION NUMBER: 0001730728-18-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 EFFECTIVENESS DATE: 20181226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZETAGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001730728 IRS NUMBER: 473365449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-328871 FILM NUMBER: 181251976 BUSINESS ADDRESS: STREET 1: 841 EAST FAYETTE STREET CITY: SYRACUSE STATE: NY ZIP: 13210 BUSINESS PHONE: 401-699-9402 MAIL ADDRESS: STREET 1: 841 EAST FAYETTE STREET CITY: SYRACUSE STATE: NY ZIP: 13210 FORMER COMPANY: FORMER CONFORMED NAME: FUSOLOGICS, INC. DATE OF NAME CHANGE: 20180213 FORMER COMPANY: FORMER CONFORMED NAME: FUSOLOGICS INC. DATE OF NAME CHANGE: 20180207 D 1 primary_doc.xml X0708 D LIVE 0001730728 ZETAGEN THERAPEUTICS, INC. 841 EAST FAYETTE STREET SYRACUSE NY NEW YORK 13210 401-699-9402 DELAWARE FUSOLOGICS, INC. FUSOLOGICS INC. Corporation true 2015 Nikhil Thakur, MD 6 Warwick Circle Andover MA MASSACHUSETTS 01890 Executive Officer Director Peter B. Finn 53 State Sreet Boston MA MASSACHUSETTS 02109 Executive Officer Director David Tischler 2272B Bryant Street San Francisco CA CALIFORNIA 94110 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2018-07-13 false true false 5000 1000000 1000000 0 false 30 0 0 0 true Some of the proceeds of the offering will be used for executive compensation. false ZETAGEN THERAPEUTICS, INC. PETER B. FINN PETER B. FINN SECRETARY 2018-12-26